... , nausea, and lymphadenopathy, frequently experienced in younger recipients (16-55 years) following the ...
... survival of 2 months. Previously healthy 17-year-old Caucasian male. Presented with 7-day history of ...
... . et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.N. Engl. J. Med.383 ...
... -021-00578-z B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination ...
... responses so that the second exposure (reinfection or vaccination dose 2) resulted in amplification of ...